Latest Insights - page 37 | BiopharmaTrend

Turn Bio Acquires Vesigen’s Microvesicle Delivery System for Epigenetic Therapies

Turn Biotechnologies, a biotechnology company based in Mountain View, California, announced on March 26, 2025, the acquisition of ARMMs (ARRDC1-Mediated Microvesicles) technology from Vesigen Therapeutics. This acquisition includes a license …

Continue ›››

seca Presents Real-Time Body Composition Tracker for GLP-1 Patients

seca, a global Hamburg-based medical measurement company founded in 1840, has introduced a new software platform called "Treatment Tracker," which integrates patients' body composition measurements with their clinical treatment plans. …

Continue ›››

Oxford Nanoimaging Launches ML-Driven Platform for Lipid Nanoparticle Characterization

Oxford Nanoimaging (ONI), founded in 2016 as a spin-out from the University of Oxford and headquartered in Oxford, UK, and San Diego, California, launched a characterization kit, which includes optimized reagents, …

Continue ›››

A Call to Improve the UK Life Sciences Sector, Home to Over 6,800 Companies

In October 2024, the UK Government released an Industrial Strategy green paper outlining a 10-year plan for the sustainable economic growth of the country and initiating the dialogue with the …

Continue ›››

Spatial Biology Company Alpenglow Biosciences Unveils 3D Imaging Interface for Light-Sheet Microscopy

Alpenglow Biosciences, a spatial biology company focused on 3D imaging, presented a new imaging interface, titled "LUMI", for light-sheet microscopy at the Association of Biomolecular Resource Facilities (ABRF) 2025 Annual …

Continue ›››

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

A new industry report from PicnicHealth reveals that nearly 80% of life sciences leaders are open to using virtual models to improve observational research, citing ongoing challenges with data completeness …

Continue ›››

YC Startup ReactWise Raises $3.4M in Pre-Seed to Develop AI-Driven Robotic Labs for Drug Manufacturing

ReactWise, a UK-based startup developing AI-driven robotic laboratories for pharmaceutical and chemical manufacturing, has raised $3.4 million in pre-seed funding. The round includes $500,000 from Y Combinator, a £1.2 million …

Continue ›››

Roivant Spinout Debuts AI Model to Combine Biomolecule Structure Prediction and Generation

VantAI, a NY-based spinout of Roivant founded in 2019, has introduced Neo-1, an artificial intelligence model that integrates atomic-level biomolecule structure prediction with molecular generation in a single framework.

Continue ›››

23andMe Files for Bankruptcy

23andMe, the consumer genetics company, has filed for Chapter 11 bankruptcy protection and initiated a sale process. The filing comes just weeks after the company rejected a takeover offer from …

Continue ›››

Lilly-Backed Ampersand Raises $65M for Preclinical Immunology and Computational Drug Discovery

Ampersand Biomedicines has raised $65 million in a Series B funding round, with participation from Eli Lilly and Company and founding firm Flagship Pioneering. The funding will be used to …

Continue ›››

Microsoft and Inait to Develop Brain-Inspired AI for Finance and Robotics

Microsoft and Swiss startup Inait have announced a partnership to develop AI models inspired by mammalian brain function. Microsoft plans to integrate Inait’s technology into its AI offerings for business …

Continue ›››

12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials

Despite undeniable progress in life sciences over the last few decades, modern healthcare faces challenges on many fronts. Lengthy drug development processes, often spanning 10 to 15 years, suboptimal clinical …

Continue ›››